◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › INVA

Innoviva, Inc. (INVA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Innoviva, Inc. (INVA) operates in the Biotechnology industry and is headquartered in Burlingame, United States with about 159 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, INVA reported $411M in revenue and $271M in net income.

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.

Interactive charts & full statements → Open the INVA valuation workbench →

INVA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$411M$359M$310M$331M
Gross Profit$334M$322M$268M$318M
Operating Income (EBIT)$164M$167M$114M$207M
Net Income$271M$23M$180M$214M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INVA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$98M$115M$108M$100M$89M
Gross Profit$82M$102M$76M$90M$80M
Operating Income (EBIT)$38M$39M$35M$49M$41M
Net Income$187M$164M$90M$64M($47M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INVA Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INVA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$1.6B$1.3B$1.2B$1.2B
Total Liabilities$462M$610M$569M$666M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INVA viewer.

Other Companies in Biotechnology

← INVAll stocksINVE →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.